November 3, 2011 – New study indicates strong diagnostic ability of treadmill exercise stress testing to uncover Long QT syndrome (LQTS) in patients. Here, investigators from the Mayo Clinic show how the recovery phase displays significant and maladaptive changes in the QTc unveiling the most common LQTS type, LQT1. The study, published in the November edition of HeartRhythm, the official journal of the Heart Rhythm Society, is the largest, single-center study of treadmill exercise stress testing in patients with genetically proven LQTS as well as those who were dismissed as normal.
The U.S. Food and Drug Administration (FDA) today approved the first transcatheter aortic heart valve in the United States - the Sapien THV. Experts say the approval will open a new chapter in how patients with severe aortic valve stenosis will be treated, without surgery.
The U.S. Food and Drug Administration (FDA) granted market clearance for the Xience Prime everolimus-eluting coronary stent system for the treatment of coronary artery disease. The stent uses the same drug and biocompatible polymer as the Xience V everolimus-eluting coronary stent system, but features an enhanced stent design and a delivery system designed for greater flexibility, better radial strength, longitudinal strength and more accurate stent placement.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
November 1, 2011 – CardioComm Solutions, a provider of hardware and software solutions for cardiovascular health management, announced the extension of their current OEM agreement with GE Healthcare. The agreement renewal means both companies will continue to play a role in the expanding cardiovascular monitoring and diagnostic devices segment, forecast recently by MarketResearch.com to grow a compound annual growth rate (CAGR) of 5 percent between now and 2017.
Philips TruFlight Select is its first economical positron emission tomography/computed tomography (PET/CT) system equipped premium time-of-flight (TOF) technology, Astonish TF. Competitive systems with similar performance can cost up to $500,000 more than the TruFlight Select PET/CT.
November 1, 2011 – Claret Medical Inc. said its Montage System has received CE mark approval as the world's first complete system of filtration to protect both carotid arteries simultaneously. The 6 French catheter is delivered via radial or brachial access, providing complete neuro protection during intravascular procedures such as transcatheter aortic valve intervention (TAVI). The unique design of the Montage System not only provides neuro-protection from debris, but also captures and removes potential stroke-causing embolic material from the body.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
November 1, 2011 – Boston Scientific released the schedule of its major events and product-related clinical research for the Cardiovascular Research Foundation's (CRF) 23rd annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, scheduled for Nov. 7-11 in San Francisco. TCT is designed to provide new insights for physicians who treat patients with cardiovascular disease and other vascular health issues.
November 1, 2011 – Volcano Corp., a developer and manufacturer of intravascular diagnosis and therapy guidance tools, said revenues for the third quarter of 2011 increased 18 percent versus the third quarter of 2010.
November 1, 2011 – Boston Scientific introduced its CardioTeach iPad app, an industry-first, free educational resource to help healthcare professionals better educate patients and caregivers about therapy options related to cardiovascular and peripheral diseases, specifically atrial and ventricular arrhythmias, coronary artery disease, heart failure, heart rhythm disorders and peripheral vascular disease.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
November 1, 2011 – The Angiographic and Imaging Core Laboratories of the Clinical Trials Center (CTC) at the Cardiovascular Research Foundation (CRF) in New York have formed a collaborative alliance with the Angiographic Core Laboratory of Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center (HFMP). Led by distinguished physicians Gregg W. Stone, Jeffrey J. Popma and Gary S. Mintz, the collaborative research alliance will be known as CRFiCOR.
November 1, 2011 – Corindus Vascular Robotics said leading experts in interventional cardiology will speak about their clinical experience using the CorPath 200 System at a symposium co-sponsored by Corindus Vascular Robotics and Philips Healthcare. The event, entitled "Robotic-Assisted PCI, User Experience in Daily Practice," will take place at 7 a.m Thursday, Nov. 10, 2011 at the Moscone Center, Room 112 at the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting.
TeraRecon will be showcasing iNtuition Cloud, the company’s flagship iNtuition solution in the form of a Web-based service at RSNA 2011.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
October 31, 2011 –Lantheus Medical announced it has been awarded a three-year supplier contract with Premier Purchasing Partners, the group purchasing unit of the Premier healthcare alliance, for its radiopharmaceutical imaging agents.
October 31, 2011 – GE Healthcare's announced in Milan, Italy, that the Lombardia Ministry of Health (MoH) purchased 135 units of GE Healthcare's pocket-sized, ultrasound medical imaging device Vscan for use by general practitioners in the region. This effort by GE Healthcare and the Lombardia MoH is not only the first of its kind for Italy, but also unique to Europe.
October 31, 2011 – NordicNeuroLab (NNL), a developer of products for functional neuroimaging, announced the launch of its magnetic resonance (MR)-compatible liquid crystal display (LCD) display. Branded the NNL LCD Monitor, the monitor is intended for use in functional MR imaging, patient comfort and relaxation, and as procedural magnetic resonance imaging (MRI) display.